Urinary albumin as a marker of future blood pressure and hypertension in the general population

Medicine (United States)

Volumn 94, Issue 6, 2015, Pages 1-7

  Takase, Hiroyuki ^a   Sugiura, Tomonori ^a   Ohte, Nobuyuki ^a   Dohi, Yasuaki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMIN URINE LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HAZARD RATIO; HEART RATE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINE LEVEL; ALBUMINURIA; FORECASTING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; URINE;

ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CREATININE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION;

EID: 84926488258     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000511     Document Type: Article

References (34)

1. Kannel WB. Hypertension as a risk factor for cardiac events: epidemiologic results of long-term studies. J Cardiovasc Pharmacol. 1993;21:S27-S37.
2. Ikeda A, Iso H, Yamagishi K, et al. Blood pressure and the risk of stroke, cardiovascular disease, and all cause mortality among Japanese: the JPHC Study. Am J Hypertens. 2009;22:273-280.
3. Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253-387.
4. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first line agents. A systematic review and meta analysis. JAMA. 1997;277:739-745.
5. Blood Pressure Lowering Treatment Trialists' Collaboration Turnbull F, Neal B, Ninomiya T, et al.. Blood pressure dependent and independent effects of agents that inhibit the renin angiotensin system. J Hypertens. 2007;25:951-958.
6. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
7. Imano H, Kitamura A, Sato S, et al. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the Circulatory Risk in Communities Study (CIRCS). Stroke. 2009;40:1571-1577.
8. Fujiyoshi A, Ohkubo T, Miura K, et al. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012;35:947-953.
9. Takashima N, Ohkubo T, Miura K, et al. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens. 2012;30:2299-2306.
10. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275:1581-1589.
11. Campese VM. Neurogenic factors and hypertension in renal disease. Kidney Int (Suppl). 2000;75:S2-S6.
12. Fukuda M, Munemura M, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int. 2004;65:621-625.
13. Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res. 2010;33:515-520.
14. Takase H, Dohi Y, Toriyama T, et al. Evaluation of risk for incident hypertension using glomerular filtration rate in the normotensive general population. J Hypertens. 2012;30:505-512.
15. Hillege HL, Janssen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519-526.
16. Tanaka S, Takase H, Dohi Y, et al. The prevalence and characteristics of microalbuminuria in the general population: a crosssectional study. BMC Res Notes. 2013;6:256.
17. Clausen P, Jensen JS, Jensen G, et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation. 2001;103:1869-1874.
18. Dogra G, Rich L, Stanton K, et al. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia. 2001;44:593-601.
19. Rossi R, Chiurlia E, Nuzzo A, et al. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol. 2004;44:1636-1640.
20. Wang TJ, Evans JC, Meigs JB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005;111:1370-1376.
21. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension. 2007;49:432-438.
22. Forman JP, Fisher ND, Schopick EL, et al. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol. 2008;19:1983-1988.
23. Kestenbaum B, Rudser KD, De Boer IH, et al. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med. 2008;148:501-508.
24. American Diabetes Association: Clinical Practice Recommendations. Diabetes care. 2001;24(suppl 1):S69-S72.
25. Mattix HJ, Hsu CY, Shaykevich S, et al. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002;13:1034-1039.
26. Teramoto T, Sasaki J, Ueshima H, et al. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb. 2007;14:155-158.
27. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-992.
28. Ballermann BJ, Stan RV. Resolved: capillary endothelium is a major contributor to the glomerular filtration barrier. J Am Soc Nephrol. 2007;18:2432-2438.
29. Murai S, Tanaka S, Dohi Y, et al. The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension. Sci Rep. 2014;4:3884.
30. Kaplan NM. Primary hypertension: natural history and evaluation. Kaplan's Clinical Hypertension. Philadelphia: Lippincott Williams & Wilkins; 2002. 136-175.
31. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988;1:335-347.
32. Law CM, De Swiet M, Osmond C, et al. Initiation of hypertension in utero and its amplification throughout life. BMJ. 1993;306:24-27.
33. Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int (Suppl). 2005;97:S68-S77.
34. Lazzara MJ, Deen WM. Model of albumin reabsorption in the proximal tubule. Am J Physiol Renal Physiol. 2007;292:F430-F439.